Macrometastasis at selective lymph node biopsy: A practical going-for-the-one clinical scoring system to personalize decision making

Table 1 Characteristics of the 95 patients with sentinel lymph nodes with macrometastases

Characteristics	n = 95	%
Age (range), yr	51.9 (23-82)	-
Average tumor size, mm	17.4	-
Tumor size
0-10	14	14.7
11-15	25	26.3
16-20	26	27.4
21-30	18	18.9
31-40	6	6.3
> 50	1	1.1
In situ	5	5.3
Menopausal status
Pre	50	52.6
Post	45	47.4
Histology type
Ductal	76	80
Lobular	15	15.8
Others	4	4.2
Phenotype
Luminal	83	87.4
Basal	9	9.5
Her-2	3	3.2
Grade
I	16	16.8
II	54	56.8
I + II	70	73.7
III	24	25.3
Unknown	1	1.1
Surgery
Conservative	63	66.3
Mastectomy	32	33.7
Number of SN removed
1	35	36.8
2	28	29.5
3	20	21.1
≥ 4	12	12.6
Nº of positive SN (Mic + MAC)
0	4	4.2
1	65	68.4
2	20	21.1
3	4	4.2
≥ 4	2	2.1
Size of the SLN metastasis
ITC (i+)	0	0
Micrometastasis (Mic)	0	0
Macrometastasis (MAC)	95	100
Number of positive SLN
0	55	57.9
1	21	22.1
2-3	11	11.6
1-3	32	33.7
≥ 4	8	8.4
Adjuvant treatments
Radiotherapy	75/90	82.4
Chemotherapy	72/90	80
Hormonotherapy	79/90	87.7
Immunotherapy	4/92	4.3

SLN: Sentinel lymph nodes.